Injecting live virus in brain tumors may fight cancer, study suggests On the brink of first-time fatherhood in 2014, Francois blacked out at work and was rushed to the hospital, where doctors found a tumor in his brain and told him he’d need surgery.
Twitter may open door to people's thoughts on heart health Twitter may be a rich vein researchers can mine for data on what people think and say about cardiovascular disease, according to a new study.
At-home tanning bed users more likely to be addicted About one in 13 people who tan indoors use their own tanning beds in the home, a new study finds.
Anxiety boosts men's risk of death from cancer, study suggests Men who experience excessive anxiety may be at increased risk of dying from cancer, a new study from Europe suggests
This dog is at the forefront of cancer research Three to four days a week, Philadelphia veterinarian Clint Kuban drops off his 3-year-old German shepherd, Tsunami, at the Penn Vet Working Dog Center for her eight-hour shift.
How tattoos can help patients with skin grafts and scars Patients who get tattoos to cover facial skin grafts and scars may feel happier with both their appearance and quality of life, a Dutch study suggests.
WHO: Excessive air pollution affects 92 percent of people More than nine out of 10 people worldwide live in areas with excessive air pollution, contributing to problems like strokes, heart disease and lung cancer, the World Health Organization said Tuesday.
Bristol-Myers to test Opdivo with Nektar drug for several cancers Bristol-Myers Squibb Co said on Tuesday it would evaluate the use of its blockbuster cancer immunotherapy Opdivo in combination with an experimental drug from Nektar Therapeutics to treat multiple cancers.
Cancer patients may be overly optimistic about early drug trial participation People with cancer may overestimate the possible benefits to them of participating in an early trial of a new medicine, even after talking with a doctor about what to expect, according to a new study from the U.K. So-called phase 1 trials of experimental treatments are intended to test the drug's safety.
